These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 23276558)
1. Effects of curcumin and demethoxycurcumin on amyloid-β precursor and tau proteins through the internal ribosome entry sites: a potential therapeutic for Alzheimer's disease. Villaflores OB; Chen YJ; Chen CP; Yeh JM; Wu TY Taiwan J Obstet Gynecol; 2012 Dec; 51(4):554-64. PubMed ID: 23276558 [TBL] [Abstract][Full Text] [Related]
2. Potential natural products for Alzheimer's disease: targeted search using the internal ribosome entry site of tau and amyloid-β precursor protein. Tasi YC; Chin TY; Chen YJ; Huang CC; Lee SL; Wu TY Int J Mol Sci; 2015 Apr; 16(4):8789-810. PubMed ID: 25903151 [TBL] [Abstract][Full Text] [Related]
3. Curcumin Decreases Hyperphosphorylation of Tau by Down-Regulating Caveolin-1/GSK-3β in N2a/APP695swe Cells and APP/PS1 Double Transgenic Alzheimer's Disease Mice. Sun J; Zhang X; Wang C; Teng Z; Li Y Am J Chin Med; 2017; 45(8):1667-1682. PubMed ID: 29132216 [TBL] [Abstract][Full Text] [Related]
4. A small molecule transcription factor EB activator ameliorates beta-amyloid precursor protein and Tau pathology in Alzheimer's disease models. Song JX; Malampati S; Zeng Y; Durairajan SSK; Yang CB; Tong BC; Iyaswamy A; Shang WB; Sreenivasmurthy SG; Zhu Z; Cheung KH; Lu JH; Tang C; Xu N; Li M Aging Cell; 2020 Feb; 19(2):e13069. PubMed ID: 31858697 [TBL] [Abstract][Full Text] [Related]
6. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons. Padmanabhan J; Levy M; Dickson DW; Potter H Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932 [TBL] [Abstract][Full Text] [Related]
7. Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome. Salminen A; Kaarniranta K; Kauppinen A; Ojala J; Haapasalo A; Soininen H; Hiltunen M Prog Neurobiol; 2013; 106-107():33-54. PubMed ID: 23827971 [TBL] [Abstract][Full Text] [Related]
8. Phosphorylated tau in neuritic plaques of APP(sw)/Tau (vlw) transgenic mice and Alzheimer disease. Pérez M; Morán MA; Ferrer I; Avila J; Gómez-Ramos P Acta Neuropathol; 2008 Oct; 116(4):409-18. PubMed ID: 18679696 [TBL] [Abstract][Full Text] [Related]
9. Amantadine as a regulator of internal ribosome entry site. Chen YJ; Zeng SJ; Hsu JT; Horng JT; Yang HM; Shih SR; Chu YT; Wu TY Acta Pharmacol Sin; 2008 Nov; 29(11):1327-33. PubMed ID: 18954527 [TBL] [Abstract][Full Text] [Related]
10. Characterization of the APP proximal promoter and 5'-untranslated regions: identification of cell type-specific domains and implications in APP gene expression and Alzheimer's disease. Lahiri DK; Ge YW; Maloney B FASEB J; 2005 Apr; 19(6):653-5. PubMed ID: 15703276 [TBL] [Abstract][Full Text] [Related]
11. The amyloid precursor protein (APP) intracellular domain regulates translation of p44, a short isoform of p53, through an IRES-dependent mechanism. Li M; Pehar M; Liu Y; Bhattacharyya A; Zhang SC; O'Riordan KJ; Burger C; D'Adamio L; Puglielli L Neurobiol Aging; 2015 Oct; 36(10):2725-36. PubMed ID: 26174856 [TBL] [Abstract][Full Text] [Related]
12. Dual action of memantine in Alzheimer disease: a hypothesis. Wu TY; Chen CP Taiwan J Obstet Gynecol; 2009 Sep; 48(3):273-7. PubMed ID: 19797019 [TBL] [Abstract][Full Text] [Related]
13. Methamphetamine exposure upregulates the amyloid precursor protein and hyperphosphorylated tau expression: The roles of insulin signaling in SH-SY5Y cell line. Chen L; Zhou L; Yu P; Fang F; Jiang L; Fei J; Xiao H; Wang J J Toxicol Sci; 2019; 44(7):493-503. PubMed ID: 31270305 [TBL] [Abstract][Full Text] [Related]
14. Anthocyanin-enriched bilberry and blackcurrant extracts modulate amyloid precursor protein processing and alleviate behavioral abnormalities in the APP/PS1 mouse model of Alzheimer's disease. Vepsäläinen S; Koivisto H; Pekkarinen E; Mäkinen P; Dobson G; McDougall GJ; Stewart D; Haapasalo A; Karjalainen RO; Tanila H; Hiltunen M J Nutr Biochem; 2013 Jan; 24(1):360-70. PubMed ID: 22995388 [TBL] [Abstract][Full Text] [Related]
15. Pharmacological modulation of GSAP reduces amyloid-β levels and tau phosphorylation in a mouse model of Alzheimer's disease with plaques and tangles. Chu J; Lauretti E; Craige CP; Praticò D J Alzheimers Dis; 2014; 41(3):729-37. PubMed ID: 24662099 [TBL] [Abstract][Full Text] [Related]
16. Amyloid-β pathology is attenuated by tauroursodeoxycholic acid treatment in APP/PS1 mice after disease onset. Dionísio PA; Amaral JD; Ribeiro MF; Lo AC; D'Hooge R; Rodrigues CM Neurobiol Aging; 2015 Jan; 36(1):228-40. PubMed ID: 25443293 [TBL] [Abstract][Full Text] [Related]
17. RNA silencing of genes involved in Alzheimer's disease enhances mitochondrial function and synaptic activity. Manczak M; Reddy PH Biochim Biophys Acta; 2013 Dec; 1832(12):2368-78. PubMed ID: 24063855 [TBL] [Abstract][Full Text] [Related]
18. Decrease in brain soluble amyloid precursor protein β (sAPPβ) in Alzheimer's disease cortex. Wu G; Sankaranarayanan S; Hsieh SH; Simon AJ; Savage MJ J Neurosci Res; 2011 Jun; 89(6):822-32. PubMed ID: 21433051 [TBL] [Abstract][Full Text] [Related]
19. Amyloid precursor protein cytoplasmic domain with phospho-Thr668 accumulates in Alzheimer's disease and its transgenic models: a role to mediate interaction of Abeta and tau. Shin RW; Ogino K; Shimabuku A; Taki T; Nakashima H; Ishihara T; Kitamoto T Acta Neuropathol; 2007 Jun; 113(6):627-36. PubMed ID: 17431643 [TBL] [Abstract][Full Text] [Related]
20. BAG-1M is up-regulated in hippocampus of Alzheimer's disease patients and associates with tau and APP proteins. Elliott E; Laufer O; Ginzburg I J Neurochem; 2009 May; 109(4):1168-78. PubMed ID: 19317853 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]